`
`17/434 464
`Application No:
`Foreign Priority claimed:
`@ Yes
`35 USC 119 (a-d) conditions met:
`Yes
`
`ONo
`CL] No
`
`Verified and Acknowledged:
`
`LC] Met After Allowance
`
`Title:
`
`Examiner's Signature
`Initials
`NOVEL PEPTIDE AND USE THEREOF
`
`GROUP ART UNIT
`
`ATTORNEY DOCKETNO.
`
` FILINGor 371(c) DATE
`
`08/27/2021
`
`RULE
`
`1654
`
`PK002174951
`
`APPLICANTS
`
`ENSOL BIOSCIENCES, INC., Daejeon, KOREA, REPUBLIC OF
`
`INVENTORS
`
`Hae Jin KIM, Daejeon, KOREA, REPUBLIC OF
`
`Eun-Joung MOON,Daejeon, KOREA, REPUBLIC OF
`
`Young Hoon LEE, Sejong, KOREA, REPUBLIC OF
`
`CONTINUING DATA
`
`This application is a 371 of PCT/KR2020/003132 03/05/2020
`
`FOREIGN APPLICATIONS
`
`KOREA, REPUBLIC OF KR10-2019-0028654 03/13/2019
`
`IF REQUIRED, FOREIGN LICENSE GRANTED**
`
`01/24/2022
`
`** SMALL ENTITY **
`
`STATE OR COUNTRY
`
`KOREA, REPUBLIC OF
`
`ADDRESS
`
`NOVICK, KIM & LEE, PLLC, dba NKL Law
`
`3251 Blenheim Blvd.
`
`SUITE 500
`
`FAIRFAX, VA 22030
`
`UNITED STATES
`
`FILING FEE RECEIVED
`
`$830
`
`